Spring Bank Pharmaceuticals to Present at Dawson James Securities 2016 Stock Growth Conference
October 13 2016 - 7:30AM
Spring Bank Pharmaceuticals Inc. (NASDAQ:SBPH), a
clinical-stage biopharmaceutical company developing novel
therapeutics for the treatment of viral infections, cancer, and
inflammatory diseases, announced today that Martin Driscoll,
President and CEO of Spring Bank Pharmaceuticals will present at
the Dawson James Securities 2016 Stock Growth Conference on
Thursday, October 20th at 10:45 AM Eastern Time at the Wyndham
Grand Hotel in Jupiter, Florida. For more information on the
conference or for investors to register, please go to DJS
Conference. To view the live audio webcast of the presentation
please go to http://ir.springbankpharm.com or
http://wsw.com/webcast/dawson2/sbph.
About Spring Bank Pharmaceuticals
Spring Bank Pharmaceuticals is a clinical-stage
biopharmaceutical company engaged in the discovery and development
of a novel class of therapeutics using its proprietary small
molecule nucleic acid hybrid, or SMNH, chemistry platform. The
company is developing its most advanced SMNH product candidate, SB
9200, for the treatment of viral diseases, including hepatitis B
virus. For more information please visit:
www.springbankpharm.com.
About Dawson James
Securities
Dawson James Securities, Inc., a member of FINRA/SIPC, is a full
service investment bank headquartered in Boca Raton, FL.
http://www.dawsonjames.com.
Contact:
Jon Freve
Chief Financial Officer
(508) 500-4956
jfreve@springbankpharm.com
Spring Bank Pharmaceutic... (NASDAQ:SBPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Spring Bank Pharmaceutic... (NASDAQ:SBPH)
Historical Stock Chart
From Apr 2023 to Apr 2024